搜索优化
English
全部
搜索
图片
视频
地图
资讯
Copilot
更多
购物
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
排序方式
最佳匹配
最新鲜
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
资讯
5 天
FDA取消自体CAR-T细胞免疫疗法风险评估与缓解策略(REMS)
2025年6月27日美国食品药品监督管理局 (FDA)宣布,取消当前已获批的BCMA及CD19靶向自体嵌合抗原受体 (CAR)T细胞免疫疗法的风险评估与缓解策略 (risk evaluation and mitigation strategy,REMS)要求。FDA认定无需REMS即可确保此类免疫疗法的安全性与有效性。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Central Texas flash floods
X CEO resigns
American Kennel Club sued
Confirmed to lead FAA
Sentenced to 8+ years
Barbie with Type 1 diabetes
Interim NASA administrator
Harvard faces subpoenas
Invests in EssilorLuxottica
14th Wimbledon semifinal
5-yr extension w/ Thunder
To buy Verona Pharma
Sinner defeats Shelton
Russia batters Ukraine
Threatens 50% Brazil tariff
Sends more tariff letters
New Mexico flooding
Turkish court bans Grok
Announces anti-graft plan
Cracker sandwiches recalled
Former Gov. DiPrete dies
Hits $4 trillion market cap
Trump admin sues California
Midair collision in Manitoba
'Click-to-cancel' blocked
Ex-doctor refuses to answer
Los Angeles joins ACLU suit
Cases hit highest level
Won't revive immigration law
Suffers serious injuries
US sanctions UN official
Greece blocks asylum claims
Christian Horner sacked
Cyclist LeMond honored
Death ruled a homicide
反馈